Comparing injection techniques for cervical lymph node mapping in endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests two different injection methods in the cervix to help map lymph nodes for endometrial cancer. The goal is to find which technique works better for staging, using a dye that helps surgeons see the lymph nodes during surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer is in the early stage (stage I). This means it hasn't spread to other parts of the body.
- Your cancer diagnosis was confirmed by imaging (CT, PET-CT) and a tissue sample.
- You have not been treated for another cancer in the last five years.
- You are not allergic to methylene blue or iodine.
- You have not had pelvic surgery or radiation to the pelvis before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a “sentinel node” biopsy, using a special dye/tracer, during surgery for early-stage endometrial cancer. It may help doctors find whether cancer has spread to lymph nodes while possibly avoiding more extensive lymph node removal.
This study compares two ways of finding and removing lymph nodes during esophageal cancer surgery. One uses a special dye (indocyanine green) to highlight lymph nodes, and the other is the standard method. The goal is to see if the dye method is as effective as the standard method while possibly being less invasive.
This trial tests whether injecting a dye called indocyanine green (ICG) in different spots can better find sentinel lymph nodes during surgery for endometrial cancer. It may help doctors remove fewer nodes and reduce side effects.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This trial tests a new method to find and remove lymph nodes in the armpit after chemotherapy shrinks breast cancer. It uses a safe blue dye to help surgeons identify which nodes to remove, potentially reducing complications while ensuring thorough treatment.
This trial compares two ways to remove lymph nodes during hysterectomy for endometrial cancer that hasn't spread. The goal is to find which method works better with similar or fewer side effects.
Hear when a new Endometrial Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.